Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

An international multicenter examination of MOG antibody assays

Journal article

WATERS P., (2019), Neurology, Neuroimmunology and Neuroinflammation

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.

Journal article

Yamamura T. et al, (2019), N Engl J Med, 381, 2114 - 2124

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling.

Journal article

Yeo T. et al, (2019), Neurol Neuroimmunol Neuroinflamm, 6

The frequency of longitudinally extensive transverse myelitis in MS: A population-based study.

Journal article

Asnafi S. et al, (2019), Mult Scler Relat Disord, 37

Causes of death in AQP4-IgG neuromyelitis optica spectrum disorder (NMOSD) in the United Kingdom NMOSD Service

Conference paper

Gibbons E. et al, (2019), MULTIPLE SCLEROSIS JOURNAL, 25, 588 - 589

Cervical cord atrophy in AQP4-Ab NMOSD, MOG-Ab disease & MS

Conference paper

Mariano R. et al, (2019), MULTIPLE SCLEROSIS JOURNAL, 25, 587 - 588

Influence of migration on the prognosis of neuromyelitis optica spectrum disorder in non-Caucasian patients

Conference paper

Soares dos Reis R. et al, (2019), MULTIPLE SCLEROSIS JOURNAL, 25, 138 - 139

Long-term safety and effectiveness of eculizumab in neuromyelitis optica spectrum disorder

Conference paper

Wingerchuk DM. et al, (2019), MULTIPLE SCLEROSIS JOURNAL, 25, 45 - 46

Load More